124 related articles for article (PubMed ID: 32381972)
21. Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma.
Sudarshan M; Alcindor T; Ades S; Aloraini A; van Huyse M; Asselah J; David M; Frechette D; Brisson S; Thirlwell M; Ferri L
Ann Surg Oncol; 2015 Jan; 22(1):324-30. PubMed ID: 25023544
[TBL] [Abstract][Full Text] [Related]
22. [A Case of Combined Modality Therapy for a Cervical Lymph Node Recurrence after Surgery for Esophageal Cancer].
Murakami H; Nishikawa K; Hirao M; Yamamoto K; Maeda S; Uemura M; Miyake M; Hama N; Ohmiya H; Miyamoto A; Miyazaki M; Ikeda M; Takami K; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1626-8. PubMed ID: 26805118
[TBL] [Abstract][Full Text] [Related]
23. [A Patient Who Had Postoperative Three-Field Lymph Node Recurrence of Cancer of the Esophagogastric Junction Obtains Complete Response by DCF Treatment].
Matono S; Mori N; Hino H; Saisho K; Nakagawa M; Fujisaki M; Tanaka T; Ishibashi N; Fujita F; Akagi Y
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1323-1326. PubMed ID: 38247073
[TBL] [Abstract][Full Text] [Related]
24. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
[TBL] [Abstract][Full Text] [Related]
26. A Pilot Trial of S-1 and Paclitaxel in Unresectable or Postoperative Recurrent Esophageal Squamous Cell Carcinoma Pretreated by Fluorouracil, Cisplatin, and Docetaxel Chemotherapy.
Nakajima Y; Kawada K; Tokairin Y; Hoshino A; Okada T; Kawano T
Dig Surg; 2018; 35(2):131-137. PubMed ID: 28554183
[TBL] [Abstract][Full Text] [Related]
27. A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy.
Shigemitsu K; Naomoto Y; Shirakawa Y; Haisa M; Gunduz M; Tanaka N
Jpn J Clin Oncol; 2002 Aug; 32(8):310-4. PubMed ID: 12411570
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer.
Rosati G; Rossi A; Tucci A; Pizza C; Manzione L
Ann Oncol; 2001 May; 12(5):669-74. PubMed ID: 11432626
[TBL] [Abstract][Full Text] [Related]
29. [Effective S-1 plus Oxaliplatin(SOX)Therapy in Two Cases of Advanced Gastric Cancer That Was Difficult to Resect and R0 Surgery Could Be Performed].
Matsumoto K; Goto A; Tajirika T; Tochii K; Kimura M; Hanatate F; Sekino T; Matsunami H
Gan To Kagaku Ryoho; 2020 Feb; 47(2):267-270. PubMed ID: 32381961
[TBL] [Abstract][Full Text] [Related]
30. [Histological complete response in a case of primary squamous cell carcinoma of the stomach treated by chemotherapy with docetaxel and cisplatin plus 5-fluorouracil].
Yanagisawa S; Tsuchiya S; Kaiho T; Togawa A; Shinmura K; Okamoto R; Nishimura M; Nomura S; Nobumoto D; Miyazaki M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):307-10. PubMed ID: 20154491
[TBL] [Abstract][Full Text] [Related]
31. [A case of squamous cell carcinoma of the esophagogastric junction with bulky no.7-metastatic node successfully treatedby chemoradiation followed by surgery].
Yoshizawa J; Koide N; Takeuchi D; Suzuki A; Shinoda A; Miyagawa S
Gan To Kagaku Ryoho; 2013 Mar; 40(3):383-7. PubMed ID: 23507604
[TBL] [Abstract][Full Text] [Related]
32. Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction.
Stahl M; Vanhoefer U; Stuschke M; Walz MK; Müller C; Wilke H
Eur J Cancer; 1998 Apr; 34(5):668-73. PubMed ID: 9713272
[TBL] [Abstract][Full Text] [Related]
33. The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma.
Hirano H; Boku N
Asia Pac J Clin Oncol; 2018 Aug; 14(4):291-299. PubMed ID: 29873183
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis.
Yamashita K; Katada N; Moriya H; Hosoda K; Mieno H; Katada C; Koizumi W; Hoshi K; Watanabe M
Gen Thorac Cardiovasc Surg; 2016 Apr; 64(4):209-15. PubMed ID: 26868531
[TBL] [Abstract][Full Text] [Related]
36. Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer.
Gao SR; Li LM; Xia HP; Wang GM; Xu HY; Wang AR
Asian Pac J Cancer Prev; 2015; 16(9):4037-40. PubMed ID: 25987082
[TBL] [Abstract][Full Text] [Related]
37. [A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
Kimura Y; Shiraishi O; Kawakami H; Ueda H; Okuno T; Hiraki Y; Kato H; Iwama M; Yasuda A; Shinkai M; Chikugo T; Imano M; Imamoto H; Nakagawa K; Yasuda T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1812-1814. PubMed ID: 30692362
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.
Mauer AM; Kraut EH; Krauss SA; Ansari RH; Kasza K; Szeto L; Vokes EE
Ann Oncol; 2005 Aug; 16(8):1320-5. PubMed ID: 15919687
[TBL] [Abstract][Full Text] [Related]
39. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
[TBL] [Abstract][Full Text] [Related]
40. [A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery].
Noumi T; Ishizaki M; Tanioka H; Yoshikawa C; Kawasaki K; Mushiaki Y; Iga N; Yoshida R; Waki N; Kawai H; Uno F; Nishi H; Yamashita K; Sonobe H
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2072-2074. PubMed ID: 32157063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
